Mark Conliffe
Neuromusculoskeletal Medicine & OMM Louisville, KY Doctor of Osteopathy
NPI 1417243999 CMS profile 1115452
506 Executive Park, Louisville, KY 40207
General payments
$75,197
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Mark Conliffe of Louisville, KY is reported in the CMS Open Payments database as having received $75,197 across 50 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 98th percentile of Neuromusculoskeletal Medicine & OMM profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $73,912 | 8 | |
| 2024 | General | $52 | 2 | |
| 2023 | General | $361 | 6 | |
| 2022 | General | $182 | 12 | |
| 2021 | General | $297 | 9 | |
| 2020 | General | $229 | 5 | |
| 2019 | General | $164 | 8 |
Beside peers
- Mark Conliffe
- Neuromusculoskeletal Medicine & OMM median
- Middle half of Neuromusculoskeletal Medicine & OMM
- National median
In program year 2025, general payments to Mark Conliffe were reported at $73,912. Among 217 Neuromusculoskeletal Medicine & OMM profiles paid that year, the median was $119 and the middle half received between $36 and $380.
Show as a table
| Year | Mark Conliffe | Neuromusculoskeletal Medicine & OMM median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $164 | $92 | $27–$283 | $163 |
| 2020 | $229 | $85 | $20–$411 | $114 |
| 2021 | $297 | $120 | $32–$548 | $132 |
| 2022 | $182 | $96 | $32–$518 | $149 |
| 2023 | $361 | $92 | $33–$328 | $160 |
| 2024 | $52 | $122 | $35–$378 | $164 |
| 2025 | $73,912 | $119 | $36–$380 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Billing to Medicare
Part B · data year 2024 · 46 billing codesPaid by Medicare
$423,650
Medicare patients
408
Services billed
6,976
| Condition among their Medicare patients | Relative to the most common | Share of patients |
|---|---|---|
| High blood pressure | 75% | |
| Arthritis | 75% | |
| Diabetes | 38% | |
| Depression | 31% | |
| Ischemic heart disease | 28% | |
| Chronic kidney disease | 23% | |
| COPD | 22% | |
| Osteoporosis | 19% |
| Drug given in the clinic | Where | Patients | Services | Paid by Medicare |
|---|---|---|---|---|
| Hyaluronan or derivitive, genvisc 850, for intra-articular injection, 1 mg J7320 | Office | 29 | 4,625 | $19,436 |
| Injection, triamcinolone acetonide, preservative-free, extended-release, microsphere formulation, 1 mg J3304 | Office | 13 | 800 | $11,052 |
Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.
Records
50 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Neuromusculoskeletal Medicine & OMM in Kentucky
Anthony Bianco
Neuromusculoskeletal Medicine & OMM · Florence, KY
Celysse Van Zyl
Neuromusculoskeletal Medicine & OMM · Lexington, KY
Edward Stiles
Neuromusculoskeletal Medicine & OMM · Pikeville, KY
Samuel Byron
Neuromusculoskeletal Medicine & OMM · Lexington, KY
Ryan Freibert
Neuromusculoskeletal Medicine & OMM · Florence, KY
Kevin Degroot
Neuromusculoskeletal Medicine & OMM · Florence, KY
Related records
Neuromusculoskeletal Medicine & OMM in Kentucky
Practitioners in the same specialty and state, ranked by reported value.
All Neuromusculoskeletal Medicine & OMM
Everyone recorded under this specialty, nationwide.
Doctors in Kentucky
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.